Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET
暂无分享,去创建一个
D Winkler | S Kasper | S. Kasper | A. Hahn | P. Baldinger | W. Wadsak | J. Ungersboeck | M. Mitterhauser | G. Karanikas | R. Frey | R. Lanzenberger | D. Winkler | R Lanzenberger | R. Lanzenberger | J Ungersboeck | M Mitterhauser | W Wadsak | A Hahn | P Stein | G Karanikas | P Baldinger | Z Micskei | R Frey | S. Kasper | P. Stein | Z. Micskei | J. Ungersboeck
[1] A. Serretti,et al. European Group for the Study of Resistant Depression (GSRD) — Where have we gone so far: Review of clinical and genetic findings , 2012, European Neuropsychopharmacology.
[2] Rupert Lanzenberger,et al. Serotonin and molecular neuroimaging in humans using PET , 2011, Amino Acids.
[3] M. Thase. Treatment-resistant depression: prevalence, risk factors, and treatment strategies. , 2011, The Journal of clinical psychiatry.
[4] H. Nijhout,et al. Bursts and the Efficacy of Selective Serotonin Reuptake Inhibitors , 2011, Pharmacopsychiatry.
[5] Clement Hamani,et al. The Subcallosal Cingulate Gyrus in the Context of Major Depression , 2011, Biological Psychiatry.
[6] Otto W. Witte,et al. Changes in Brain Size during the Menstrual Cycle , 2011, PloS one.
[7] J. Kenemans,et al. Prefrontal Mechanisms of Fear Reduction After Threat Offset , 2010, Biological Psychiatry.
[8] Rupert Lanzenberger,et al. Escitalopram Enhances the Association of Serotonin-1A Autoreceptors to Heteroreceptors in Anxiety Disorders , 2010, The Journal of Neuroscience.
[9] Rupert Lanzenberger,et al. Cortisol plasma levels in social anxiety disorder patients correlate with serotonin-1A receptor binding in limbic brain regions. , 2010, The international journal of neuropsychopharmacology.
[10] D. McLoughlin,et al. Objective Cognitive Performance Associated with Electroconvulsive Therapy for Depression: A Systematic Review and Meta-Analysis , 2010, Biological Psychiatry.
[11] T. Suhara,et al. Effect of electroconvulsive therapy on 5-HT1A receptor binding in patients with depression: a PET study with [11C]WAY 100635. , 2010, The international journal of neuropsychopharmacology.
[12] V. Sossi,et al. Effect of electroconvulsive therapy on brain 5-HT2 receptors in major depression , 2010, British Journal of Psychiatry.
[13] G. Kranz,et al. Reward and the serotonergic system , 2010, Neuroscience.
[14] J. Hornung. CHAPTER 1.3 - The Neuronatomy of the Serotonergic System , 2010 .
[15] Barry L. Jacobs,et al. Handbook of the behavioral neurobiology of serotonin , 2010 .
[16] S Kasper,et al. Influence of escitalopram treatment on 5-HT1A receptor binding in limbic regions in patients with anxiety disorders , 2009, Molecular Psychiatry.
[17] Rupert Lanzenberger,et al. The Serotonin-1A Receptor in Anxiety Disorders , 2009, Biological Psychiatry.
[18] Ramin V. Parsey,et al. Positron Emission Tomography Quantification of Serotonin-1A Receptor Binding in Medication-Free Bipolar Depression , 2009, Biological Psychiatry.
[19] Christer Halldin,et al. Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[20] I. Lucki,et al. 5-HT1A receptor function in major depressive disorder , 2009, Progress in Neurobiology.
[21] Siegfried Kasper,et al. Lateralization of the serotonin-1A receptor distribution in language areas revealed by PET , 2009, NeuroImage.
[22] D. Nutt,et al. Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study. , 2008, The British journal of psychiatry : the journal of mental science.
[23] W. Drevets,et al. The Subgenual Anterior Cingulate Cortex in Mood Disorders , 2008, CNS Spectrums.
[24] Rupert Lanzenberger,et al. The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-11C]WAY-100635 , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[25] Juha Markkula,et al. Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. , 2008, The international journal of neuropsychopharmacology.
[26] D. Nutt,et al. Serotonin 5-HT 1 A receptor binding in people with panic disorder : positron emission tomography study , 2008 .
[27] D. Kupfer,et al. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. , 2007, Nuclear medicine and biology.
[28] Rupert Lanzenberger,et al. Simple and fully automated preparation of [carbonyl-11C]WAY-100635 , 2007 .
[29] D. Kupfer,et al. Measurement of 5‐HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY‐100635 , 2007, Synapse.
[30] R. P. Maguire,et al. Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[31] Wolfgang Wadsak,et al. Reduced Serotonin-1A Receptor Binding in Social Anxiety Disorder , 2007, Biological Psychiatry.
[32] Hans-Jürgen Möller,et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care , 2007, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[33] W J Riedel,et al. Serotonergic vulnerability and depression: assumptions, experimental evidence and implications , 2007, Molecular Psychiatry.
[34] G. Weniger,et al. Abnormal size of the amygdala predicts impaired emotional memory in major depressive disorder. , 2006, Journal of affective disorders.
[35] Ramin V. Parsey,et al. Altered Serotonin 1A Binding in Major Depression: A [carbonyl-C-11]WAY100635 Positron Emission Tomography Study , 2006, Biological Psychiatry.
[36] D. Doudet,et al. Electroconvulsive shock decreases binding to 5-HT2 receptors in nonhuman primates: An in vivo positron emission tomography study with [18F]setoperone , 2005, Biological Psychiatry.
[37] A. Scott,et al. Electroconvulsive therapy in depressive illness that has not responded to drug treatment. , 2004, Journal of affective disorders.
[38] C. Halldin,et al. Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain , 2004, Human brain mapping.
[39] Peter Herscovitch,et al. Reduced Serotonin Type 1A Receptor Binding in Panic Disorder , 2004, The Journal of Neuroscience.
[40] Decreased 5-HT 1A Receptor Binding in Amygdala of , 2004 .
[41] G. Goodwin,et al. Attenuation by electroconvulsive shock and antidepressant drugs of the 5-HT1A receptor-mediated hypothermia and serotonin syndrome produced by 8-OH-DPAT in the rat , 2004, Psychopharmacology.
[42] Jeih-San Liow,et al. Linearized Reference Tissue Parametric Imaging Methods: Application to [11C]DASB Positron Emission Tomography Studies of the Serotonin Transporter in Human Brain , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[43] Glyn Lewis,et al. Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression , 2002, British Journal of Psychiatry.
[44] Richard I. Abrams. Electroconvulsive therapy (ECT) practice in Metropolitan New York community hospitals. , 2002, Psychological medicine.
[45] Richard Abrams,et al. Stimulus Titration and ECT Dosing , 2002, The journal of ECT.
[46] N. Tzourio-Mazoyer,et al. Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.
[47] H. Möller,et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder , 2002, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[48] M. Mintun,et al. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study , 2001, Biological Psychiatry.
[49] S. Kasper,et al. Einsatz der Elektrokrampftherapie in der Psychiatrie , 2001, Der Nervenarzt.
[50] H. Sackeim,et al. Decreased regional brain metabolism after ect. , 2001, American Journal of Psychiatry.
[51] R. Frey,et al. [Use of electroconvulsive therapy in psychiatry]. , 2001, Der Nervenarzt.
[52] A. Zis,et al. A Preliminary Study of the Effects of Electroconvulsive Therapy on Regional Brain Glucose Metabolism in Patients with Major Depression , 2000, The journal of ECT.
[53] S H Lisanby,et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. , 2000, Archives of general psychiatry.
[54] P A Sargent,et al. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. , 2000, Archives of general psychiatry.
[55] J. Markowitz,et al. Background information and treatment recommendations for patients with HIV/AIDS , 2000 .
[56] J. Markowitz,et al. Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. , 2000, The American journal of psychiatry.
[57] Expression of 5-HT receptors and the 5-HT transporter in rat brain after electroconvulsive shock , 1999, Neuroscience Letters.
[58] D. Kupfer,et al. Pet imaging of serotonin 1A receptor binding in depression , 1999, Biological Psychiatry.
[59] S. Kapur,et al. Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study. , 1999, The American journal of psychiatry.
[60] S. Yamawaki,et al. Enhancement of serotonin(1A) receptor function following repeated electroconvulsive shock in young rat hippocampal neurons in vitro. , 1999, The international journal of neuropsychopharmacology.
[61] G. Rajkowska,et al. Increase in Serotonin-1A Autoreceptors in the Midbrain of Suicide Victims with Major Depression—Postmortem Evidence for Decreased Serotonin Activity , 1998, The Journal of Neuroscience.
[62] C. Nemeroff,et al. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. , 1997, The Journal of pharmacology and experimental therapeutics.
[63] N. Michael,et al. Electroconvulsive therapy vs. paroxetine in treatment‐resistant depression — a randomized study , 1997, Acta psychiatrica Scandinavica.
[64] H L Miller,et al. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. , 1997, Archives of general psychiatry.
[65] H. Wikström,et al. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]WAY-100635 , 1997, Brain Research.
[66] H. Sackeim,et al. Resistance to antidepressant medications and short-term clinical response to ECT. , 1996, The American journal of psychiatry.
[67] P. Blier,et al. Effect of repeated electroconvulsive shocks on serotonergic neurons. , 1992, European journal of pharmacology.
[68] C. Montigny,et al. Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat. , 1991, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[69] J. Mcculloch,et al. Local cerebral glucose utilization after chronic electroconvulsive shock: implications for the mode of action of electroconvulsive therapy , 1991, Journal of psychopharmacology.
[70] H. Sackeim,et al. The Impact of Medication Resistance and Continuation Pharmacotherapy on Relapse following Response to Electroconvulsive Therapy in Major Depression , 1990, Journal of clinical psychopharmacology.
[71] C. Stockmeier,et al. Electroconvulsive shock decreases β-adrenoceptors despite serotonin lesions , 1988 .
[72] N. Volkow,et al. Effects of Electroconvulsive Therapy on Brain Glucose Metabolism: A Preliminary Study. , 1988, Convulsive therapy.
[73] J. Engel,et al. Positron Emission Tomography and Autoradiographic Studies of Glucose Utilization following Electroconvulsive Seizures in Humans and Rats a , 1986, Annals of the New York Academy of Sciences.
[74] H. Sackeim,et al. Acute Reductions of Regional Cerebral Blood Flow following Electroconvulsive Therapy a , 1986, Annals of the New York Academy of Sciences.
[75] D. Charney,et al. Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects. , 1984, Archives of general psychiatry.
[76] C. Montigny. Electroconvulsive shock treatments enhance responsiveness of forebrain neurons to serotonin. , 1984 .
[77] C. de Montigny. Electroconvulsive shock treatments enhance responsiveness of forebrain neurons to serotonin. , 1984, The Journal of pharmacology and experimental therapeutics.
[78] M E Phelps,et al. Patterns of human local cerebral glucose metabolism during epileptic seizures. , 1982, Science.
[79] H. Akiskal,et al. Depressive Disorders: Toward a Unified Hypothesis , 1973, Science.
[80] J. Schildkraut,et al. The catecholamine hypothesis of affective disorders. A review of supporting evidence. , 1967, International journal of psychiatry.